214 related articles for article (PubMed ID: 38171406)
1. Advances and prospects of mRNA vaccines in cancer immunotherapy.
Liu Y; Yan Q; Zeng Z; Fan C; Xiong W
Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189068. PubMed ID: 38171406
[TBL] [Abstract][Full Text] [Related]
2. mRNA vaccine for cancer immunotherapy.
Miao L; Zhang Y; Huang L
Mol Cancer; 2021 Feb; 20(1):41. PubMed ID: 33632261
[TBL] [Abstract][Full Text] [Related]
3. The viral approach to breast cancer immunotherapy.
Arab A; Behravan N; Razazn A; Barati N; Mosaffa F; Nicastro J; Slavcev R; Behravan J
J Cell Physiol; 2019 Feb; 234(2):1257-1267. PubMed ID: 30146692
[TBL] [Abstract][Full Text] [Related]
4. Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics.
Guo ZS; Lu B; Guo Z; Giehl E; Feist M; Dai E; Liu W; Storkus WJ; He Y; Liu Z; Bartlett DL
J Immunother Cancer; 2019 Jan; 7(1):6. PubMed ID: 30626434
[TBL] [Abstract][Full Text] [Related]
5. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
Medikonda R; Pant A; Lim M
Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
[TBL] [Abstract][Full Text] [Related]
7. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
Deng Z; Tian Y; Song J; An G; Yang P
Front Immunol; 2022; 13():887125. PubMed ID: 35720301
[TBL] [Abstract][Full Text] [Related]
8. Design of Personalized Neoantigen RNA Vaccines Against Cancer Based on Next-Generation Sequencing Data.
Alburquerque-González B; López-Abellán MD; Luengo-Gil G; Montoro-García S; Conesa-Zamora P
Methods Mol Biol; 2022; 2547():165-185. PubMed ID: 36068464
[TBL] [Abstract][Full Text] [Related]
9. Highlights into historical and current immune interventions for cancer.
Cole K; Al-Kadhimi Z; Talmadge JE
Int Immunopharmacol; 2023 Apr; 117():109882. PubMed ID: 36848790
[TBL] [Abstract][Full Text] [Related]
10. mRNA vaccines for cancer immunotherapy.
Vishweshwaraiah YL; Dokholyan NV
Front Immunol; 2022; 13():1029069. PubMed ID: 36591226
[TBL] [Abstract][Full Text] [Related]
11. Combining Tumor Vaccination and Oncolytic Viral Approaches with Checkpoint Inhibitors: Rationale, Pre-Clinical Experience, and Current Clinical Trials in Malignant Melanoma.
Cavalcante L; Chowdhary A; Sosman JA; Chandra S
Am J Clin Dermatol; 2018 Oct; 19(5):657-670. PubMed ID: 29961183
[TBL] [Abstract][Full Text] [Related]
12. mRNA Cancer Vaccines: Construction and Boosting Strategies.
Liu X; Huang P; Yang R; Deng H
ACS Nano; 2023 Oct; 17(20):19550-19580. PubMed ID: 37819640
[TBL] [Abstract][Full Text] [Related]
13. Clinical advances and ongoing trials on mRNA vaccines for cancer treatment.
Lorentzen CL; Haanen JB; Met Ö; Svane IM
Lancet Oncol; 2022 Oct; 23(10):e450-e458. PubMed ID: 36174631
[TBL] [Abstract][Full Text] [Related]
14. [Preventive vaccines and immunotherapy clinical trials against cervical cancer].
Valdespino-Gómez VM
Cir Cir; 2005; 73(1):57-69. PubMed ID: 15888272
[TBL] [Abstract][Full Text] [Related]
15. Nanomedicine for advanced cancer immunotherapy.
Diep YN; Kim TJ; Cho H; Lee LP
J Control Release; 2022 Nov; 351():1017-1037. PubMed ID: 36220487
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract][Full Text] [Related]
17. Current research into novel therapeutic vaccines against cervical cancer.
Cordeiro MN; De Lima RCP; Paolini F; Melo ARDS; Campos APF; Venuti A; De Freitas AC
Expert Rev Anticancer Ther; 2018 Apr; 18(4):365-376. PubMed ID: 29475377
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of glioblastoma: Recent advances and future prospects.
Yuan B; Wang G; Tang X; Tong A; Zhou L
Hum Vaccin Immunother; 2022 Nov; 18(5):2055417. PubMed ID: 35344682
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials.
Tang J; Li M; Zhao C; Shen D; Liu L; Zhang X; Wei L
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215833
[TBL] [Abstract][Full Text] [Related]
20. The potential of mRNA vaccines in cancer nanomedicine and immunotherapy.
Pan S; Fan R; Han B; Tong A; Guo G
Trends Immunol; 2024 Jan; 45(1):20-31. PubMed ID: 38142147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
